[68Ga]Ga-DOTA-TOC PET/CT 对胰腺神经内分泌肿瘤定性的增益价值:与增强 CT 和/或 MRI 的大样本比较
该回顾性研究纳入 167 例疑似胰腺 NEN 患者,比较放射科医生单独阅读增强 CT 和/或 MRI 与联合 [68Ga]Ga-DOTA-TOC PET/CT 的诊断效能。以病理为参考标准,联合 PET/CT 后 AUC 和敏感度均显著提高,尤其在不典型强化模式的 NEN 中。
要点
- 联合 [68Ga]Ga-DOTA-TOC PET/CT 可显著提高疑似胰腺 NEN 的 AUC 和敏感度。
- 增益在不典型强化模式的 NEN 中尤为显著。
- 联合 PET/CT 后观察者间一致性改善。
核心结论
- [68Ga]Ga-DOTA-TOC PET/CT 在疑似胰腺 NEN 的定性方面较常规 CT 或 MRI 提供额外价值。
研究设计与样本
- 回顾性研究纳入 167 例因疑似胰腺 NEN 行 [68Ga]Ga-DOTA-TOC PET/CT 的患者。
- 所有患者均经增强 CT(n=153)和/或 MRI(n=85)检出疑似病灶。
- 两名放射科医生独立阅读 CT 和/或 MRI 及 PET/CT,采用 5 分法评分 NEN 概率。
- 以病理(手术 n=93 或活检 n=74)为参考标准,比较联合 PET/CT 前后的诊断效能。
诊断标准与关键数值
- 最终病理诊断 NEN 131 例,非 NEN 36 例。
- CT 阅读者1 AUC 从 0.737 升至 0.886(p=0.0004),阅读者2 从 0.709 升至 0.859(p=0.0002)。
- MRI 阅读者1 AUC 从 0.748 升至 0.872(p=0.023),阅读者2 从 0.670 升至 0.854(p=0.001)。
- CT 敏感度阅读者1 从 87.4% 升至 96.6%(p=0.001),阅读者2 从 74.8% 升至 92.5%(p=0.0001)。
- MRI 敏感度阅读者1 从 86.9% 升至 98.4%(p=0.016),阅读者2 从 70.5% 升至 91.8%(p=0.002)。
临床应用与阅片要点
- 对常规 CT/MRI 表现不典型(如不典型强化模式)的疑似胰腺 NEN,建议加做 [68Ga]Ga-DOTA-TOC PET/CT 以提高定性准确度。
- 联合 PET/CT 可提高诊断敏感度并改善观察者间一致性,有助于减少漏诊。
局限性
- 回顾性研究设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To investigate an additional value of [68Ga]Ga-DOTA-TOC PET/CT for characterizing suspected pancreatic neuroendocrine neoplasms (NENs) in a large study cohort.
METHODS: This retrospective study included 167 patients who underwent [68Ga]Ga-DOTA-TOC PET/CT for suspected pancreatic NENs detected by contrast-enhanced CT (n = 153) and/or MRI (n = 85). Two board-certified radiologists independently reviewed CT and/or MRI as well as [68Ga]Ga-DOTA-TOC PET/CT and scored the probability of NEN on a 5-point scale. Radiologists' diagnostic performances with and without [68Ga]Ga-DOTA-TOC PET/CT were compared using pathologic findings as the standard of reference.
RESULTS: All 167 patients were pathologically diagnosed with NENs (n = 131) or non-NENs (n = 36) by surgery (n = 93) or biopsy (n = 74). The non-NEN group included focal pancreatitis (n = 7), gastrointestinal stromal tumor (n = 6), serous cystadenoma (n = 5), metastatic renal cell carcinoma (n = 4), intrapancreatic accessory spleen (n = 4), ductal adenocarcinoma (n = 3), solid pseudopapillary neoplasm (n = 2), intraductal papillary mucinous carcinoma (n = 1), adenosquamous carcinoma (n = 1), schwannoma (n = 1), paraganglioma (n = 1), and solitary fibrous tumor (n = 1). Radiologists' diagnostic performance significantly improved after the addition of [68Ga]Ga-DOTA-TOC PET/CT (AUC of CT: 0.737 vs. 0.886 for reviewer 1 [p = 0.0004]; 0.709 vs. 0.859 for reviewer 2 [p = 0.0002], AUC of MRI: 0.748 vs. 0.872 for reviewer 1 [p = 0.023]; 0.670 vs. 0.854 for reviewer 2 [p = 0.001]). [68Ga]Ga-DOTA-TOC PET/CT significantly improved sensitivity (CT: 87.4% vs. 96.6% for reviewer 1 [p = 0.001]; 74.8% vs. 92.5% for reviewer 2 [p = 0.0001], MRI: 86.9% vs. 98.4% for reviewer 1 [p = 0.016]; 70.5% vs. 91.8% for reviewer 2 [p = 0.002]).
CONCLUSIONS: [68Ga]Ga-DOTA-TOC PET/CT provided an additional value over conventional CT or MRI for the characterization of suspected pancreatic NENs.
KEY POINTS: • [68Ga]Ga-DOTA-TOC PET/CT could provide additional value over conventional CT and/or MRI for the exact characterization of suspected pancreatic NENs by increasing AUC values and sensitivity. • Diagnostic improvement was significant, especially in NENs showing an atypical enhancement pattern. • The inter-observer agreement was improved when [68Ga]Ga-DOTA-TOC PET/CT was added to CT and/or MRI.
引用
- Yoo J, Kim SH, Jeon SK, et al. Added value of [68Ga]Ga-DOTA-TOC PET/CT for characterizing pancreatic neuroendocrine neoplasms: a comparison with contrast-enhanced CT and/or MRI in a large study cohort. Eur Radiol. 2021. PMID: 33787974. doi:10.1007/s00330-021-07859-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。